Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation.

MLA

Hulshof, Anne-Marije, et al. “Serial EXTEM, FIBTEM, and TPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation.” Frontiers in Cardiovascular Medicine, vol. 8, Apr. 2021, p. 654174. EBSCOhost, https://doi.org/10.3389/fcvm.2021.654174.

APA

Hulshof, A.-M., Brüggemann, R. A. G., Mulder, M. M. G., van de Berg, T. W., Sels, J.-W. E. M., Olie, R. H., Spaetgens, B., Streng, A. S., Verhezen, P., van der Horst, I. C. C., Ten Cate, H., Spronk, H. M. H., van Bussel, B. C. T., & Henskens, Y. M. C. (2021). Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation. Frontiers in Cardiovascular Medicine, 8, 654174. https://doi.org/10.3389/fcvm.2021.654174

Chicago

Hulshof, Anne-Marije, Renée A G Brüggemann, Mark M G Mulder, Tom W van de Berg, Jan-Willem E M Sels, Renske H Olie, Bart Spaetgens, et al. 2021. “Serial EXTEM, FIBTEM, and TPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation.” Frontiers in Cardiovascular Medicine 8 (April): 654174. doi:10.3389/fcvm.2021.654174.